Table 1.
Fasting glucose measurements | Change in insulin glargine dose |
---|---|
>5.6 mmol/L (100 mg/dL) (on 3 consecutive mornings) | Increase dose by 2 IU |
>10.0 mmol/L (180 mg/dL) (on 3 consecutive mornings) | Increase dose by 4 IU |
≤3.9 mmol/L (70 mg/dL) (at any time) | Contact study physician for insulin dose (if study physician not reached prior to next dose, dose reduced by 4 IU) |
Goal was fasting glucose of 4.0–5.6 mmol/L (72–100 mg/dL)